On July 13, 2020 Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151) a global specialty pharmaceutical company, reported that it is establishing a general grant program to support the education of African-American patients about cutaneous T-cell lymphomas (CTCL) and address racial disparities in diagnosis, treatment and outcomes (Press release, Kyowa Hakko Kirin, JUL 13, 2020, View Source [SID1234561837]). Studies have shown that African-American patients present symptoms of CTCL at an earlier age, and overall survival is significantly shorter for African-American patients with MF, when compared to patients of European descent.1,2 The goal of the grant program is to identify and fund meaningful projects that can help diminish these disparities.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

With this RFP, we seek to identify and fund patient education grants to educate African American patients about CTCL and help address existing racial disparities in diagnosis, treatment and patient outcomes.
With this RFP, we seek to identify and fund patient education grants to educate African American patients about CTCL and help address existing racial disparities in diagnosis, treatment and patient outcomes.
Kyowa Kirin is seeking project proposals that can help to close gaps in awareness and understanding of CTCL among African-American communities, including its prevalence and epidemiology, risk factors, diagnosis and care pathways, and improve outreach. Applications for funds are due by August 20, 2020.

"New data, targeted outreach and education is needed to address barriers and increase awareness among African-Americans so they can be diagnosed at an earlier stage," says Lauren Walrath, Senior Director, Head of Public Affairs, North America. "Kyowa Kirin is seeking to sponsor work that can have a profound patient impact. We hope this grant program will encourage researchers and organizations with an interest in helping the African-American patient community improve outcomes."

Kyowa Kirin encourages proposals from the following individuals or organizations who are focused on a mission related to patient education and/or healthcare improvement: Patient advocacy organizations or non-profit foundations; organizations dedicated to African-American empowerment and/or healthcare; public health/social work/nursing/pharmacy schools or students within these schools; healthcare institutions (both large and small); and other entities with a mission related to patient education and/or healthcare improvement.

Kyowa Kirin will make $100,000 available in funds to support these initiatives over a six-month period, starting October 1, 2020. Individual projects requesting up to $35,000 will be considered.

Proposals and questions should be submitted to the North America Grant Review Committee mailbox at [email protected] by August 20, 2020.